
Author: Leanne Maria Braganca, MDS
Medical Reviewer: Azuka Chinweokwu Ezeike, MBBS, FWACS, FMCOG, MSc (PH)
We live in times when everyone is attempting to be more health-conscious and take better care of themselves. These efforts have extended beyond general health, with people even taking care of their overall wellness and mental health too. There is a growing understanding of how some problems are not just ‘skin-deep’. They can affect a person’s well-being in different ways.
Melasma is one such chronic skin condition that affects around 1% of the global population. It is characterised by flat brown patches that occur on sun-exposed areas of the body, particularly the face. It occurs more commonly in women, particularly those of childbearing age with a darker skin type [1].
While melasma isn't painful and doesn't pose any health risks, it can cause significant emotional distress because of its effect on a person’s facial appearance.
This article explains what melasma is, the factors that contribute to or put you at risk for melasma, as well as how to prevent it from happening. It also outlines the signs to look out for and the treatment strategies that are used to manage melasma.
Melasma presents as hyperpigmented patches where the skin appears darker than the rest of the skin around them. These patches are distributed symmetrically on areas exposed to the sun, such as the:
Melasma is not contagious, not painful or itchy, and is a harmless condition. However, since it affects a person’s appearance, it can cause emotional distress and affect a person’s quality of life. Patients commonly report feelings of shame, low self-esteem, dissatisfaction, and a lack of motivation to go out [3].
Melasma occurs when the pigment-producing cells in the skin create excess melanin.This is believed to be caused by multiple factors, including [3,4,5]:
Ultraviolet rays from the sun stimulate the pigment-producing cells in the skin (known as the ‘melanocytes’) to produce excess melanin. This can lead to darkening of existing melasma patches or formation of new ones.
Melasma pigmentation usually improves in the winter and worsens in the summer (or immediately after intense sun exposure).
40% of patients reported having relatives affected with the disease.
Fluctuations in levels of hormones, especially female sex hormones ( due to oral contraceptive use, hormone replacement therapy, or pregnancy), can increase melanin production and lead to melasma.
Melasma during the second trimester of pregnancy is known as “mask of pregnancy” or “chloasma gravidarum”. In these cases, melasma is temporary and resolves within a year after delivery. However, it can recur during subsequent pregnancies.
Taking medications such as birth control pills, steroids, clomipramine, and phototoxic drugs (that make the skin sensitive to sunlight), such as retinoids.
Conditions such as Hashimoto’s thyroiditis and Graves’ disease can lead to altered levels of thyroid hormones, which may influence melanocyte activity and result in melasma
Some people are more likely to develop melasma than others. These include: [3,6]
Photoaging (premature ageing of the skin caused by long-term sun exposure) can affect the skin’s ability to heal and repair. This can prolong melasma and make it harder to treat.
Melasma is diagnosed and differentiated from other similar-looking skin conditions based on: [3,7]
Typically gradual
Irregularly shaped flat brown or brownish-grey patches
Occasionally, your doctor may take a small piece of the skin (biopsy) for examination under the microscope to rule out other similar-looking conditions. Consulting your healthcare provider is important to identify the cause of the skin pigmentation and rule out other causes, such as autoimmune disorders, endocrine disorders, and skin cancer.
Sun exposure is the greatest triggering and worsening factor in melasma. Sun protection must be continued indefinitely because UV exposure can lead to recurrence of melasma.
Some ways to do this include:
This should include avoiding going outdoors, as well as staying away from windows, since UVA and visible light can penetrate through clouds and window panes.
Hydroquinone
Important points to note:
Tranexamic acid (TXA)
While melasma cannot be entirely prevented from happening, it is possible to prevent it from worsening. This can be done by [7-9]:
Melasma is a common and harmless condition. Management of melasma requires patient-centred care with a combination of medical management, patient education, and psychosocial support. Doing this can help achieve better care and improved quality of life for those dealing with this challenging condition.
No. Melasma cannot be completely cured. However, there are various treatments and preventive strategies that can help keep it under control.
No, melasma and skin cancer are two separate conditions. Be sure to consult your doctor if you notice any unusual, changing, raised, or irregular spots on your skin to rule out more serious and life-threatening conditions such as skin cancer.
No. Melasma is not contagious.
1. Miao F, Wan J, Zhou Y, Shi Y. Unraveling melasma: From epidermal pigmentation to microenvironmental dysregulation. Biology. 2025 Oct 13;14(10):1402–2. Available from: https://www.mdpi.com/2079-7737/14/10/1402
2.Syder NC, Elbuluk N. The history of melasma: Its roots and evolution. Dermatological Reviews. 2022 June 6;4(1):5–11. Available from: https://onlinelibrary.wiley.com/doi/10.1002/der2.134
3. Handel AC, Miot LDB, Miot HA. Melasma: A clinical and epidemiological review. Anais Brasileiros de Dermatologia. 2014 Sept ;89(5):771–82. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155956/
4. Zhao L, Fu X, Cheng H. Prevention of melasma during pregnancy: Risk factors and photoprotection-focused strategies. Clinical, Cosmetic and Investigational Dermatology. 2024 Oct;Volume 17:2301–10. Available from: https://www.tandfonline.com/doi/full/10.2147/CCID.S488663#abstract
5. Qu Y, Wang S, Xie H, Meng X, Cui B, Xiao Z. Melasma secondary to drugs: A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS). BMC Pharmacology and Toxicology. 2025 Mar 31;26(1). Available from: https://link.springer.com/article/10.1186/s40360-025-00912-4
6. R DK, Sood R, Tiwari P. Melasma management: Unveiling recent breakthroughs through literature analysis. Health Sciences Review. 2025 Mar;14:100213. Available from: https://www.sciencedirect.com/science/article/pii/S2772632025000054
7. Basit H, Godse KV, Al Aboud AM. Melasma. PubMed. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2026 Oct 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459271/
8. Lyons AB, Trullas C, Kohli I, Hamzavi IH, Lim HW. Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens. J Am Acad Dermatol. 2021;84(5):1393-1397. Available from: https://pubmed.ncbi.nlm.nih.gov/32335182/
9. Jo JY, Chae SJ, Ryu HJ. Update on Melasma Treatments. Ann Dermatol. 2024;36(3):125-134. Available from:https://pmc.ncbi.nlm.nih.gov/articles/PMC11148313/
Disclaimer:
The information provided on this website is for general educational and informational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Published October 26, 2026